Jeremy Chia, analyst at Compounder Fund, Galilee Investment Management, shares what the upsides and risks are for investors buying into vaccine makers like Moderna and BioNTech.
ST: The Big Story, 25 Oct
The middle of earnings season in the US, Turkish Lira & Shibu Inu
Market View Minute with Michelle: Korean Entertainment